デフォルト表紙
市場調査レポート
商品コード
1301071

ロングリードシーケンスの市場規模、シェア、動向分析レポート:製品別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年

Long Read Sequencing Market Size, Share & Trends Analysis Report By Product, By Technology (Nanopore Sequencing), By Workflow, By Application, By End-Use, By Region And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 180 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ロングリードシーケンスの市場規模、シェア、動向分析レポート:製品別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年06月19日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ロングリードシーケンス市場の成長と動向

GrandView Research, Inc.の最新レポートによると、ロングリードシーケンスの世界市場規模は2030年までに37億8,000万米ドルに達し、CAGRは30.92%に達すると予測されています。

シーケンス法は医薬品の改変において最も重要であることが示されているため、ロングリードシーケンスの知識の拡大にも累積的な市場価値があります。構造バリアントの解析にこれらの技術を採用するケースが増加しており、予測期間を通じて市場を牽引すると予想されます。

現在、多くの研究が行われており、これはメーカーが新しく先進的なロングリードシーケンスを開発する際に若干有利になると予測され、またロングリードシーケンス市場において他の多くの展望を開くと予測されます。さらに、現在進行中のCOVID-19パンデミックのため、主要企業は世界中の公衆衛生研究所や研究者と協力し、新型コロナウイルスSARS-CoV-2の迅速なシーケンスによって現在のCOVID-19パンデミックを支援しています。

各社はまた、サンプル中のさまざまな病原体を特徴付けるワークフローの開発にも取り組んでいます。最近では、Oxford Nanopore Technologies社が、SARS-CoV-2を検出するためのスケーラブルで低コストの迅速アッセイであるLamPOREを開発しました。遺伝子疾患の有病率の上昇と、ロングリードシーケンス技術に対するトップメーカーの研究開発費の増加が相まって、この業界は大きく発展すると予測されています。ロングリード技術は、疾患遺伝子座が既知であるか強く疑われる遺伝性疾患の研究に主に使用されます。

さらに、次世代シーケンサーに基づく臨床疾患研究の限界は、これらの技術によって部分的に克服される可能性があります。DNA1分子からのより長いリードが使用されるため、ロングリードシーケンス法は他の技術よりも明らかに有利です。市場拡大のもう1つの促進要因は、医療診断のための現代的手法が受け入れられつつあることです。LRS技術の可搬性とリアルタイムの速さは、さらに需要増加の要因となっています。

さらに、染色体セントロメアの正確な参照地図を作成するためにも利用されています。さらに、多くのバイオテクノロジー企業が、ライブラリー調製への新たなアプローチとゲノム解析のためのツールを組み合わせた最先端技術を開発しています。従って、多くの調査から、LRS技術は、遺伝的起源が不明なヒト疾患における新規の有害変異の同定に極めて有用であることが示されています。このことは、研究者が全ゲノムシーケンス(WGS)技術を利用して遺伝医学を発展させる可能性を豊富に提供しています。

ロングリードシーケンス市場レポートハイライト

  • 技術別では、単一分子リアルタイムシーケンス(SMRT)が2021年の市場を独占しました。この技術は、最初の商業的発売以来、さまざまな用途で専門家の間で人気を集めている
  • 製品別では、消耗品セグメントが2022年に最大シェアを占めました。試薬・キットに対する需要の増加が、このセグメントの成長を大きく牽引しています。
  • 用途別では、がん分野が2022年に最も高いシェアを獲得しました。がん生物学分野でのLRS採用の増加がセグメント成長の主要因と予測されます。
  • ワークフロー別では、シーケンシングが2022年のセグメントを支配しています。ゲノミクス分野における調査の増加により、世界市場におけるシーケンスサービスの需要が高まっています。
  • 最終用途別では、学術研究が2022年に大きなシェアを占める。ゲノミクスの方法論を探求するバイオテクノロジー研究機関が多数存在することが、同分野の収益創出を促進すると期待されています。
  • 北米は、プロテオミクス、ゲノミクス、腫瘍学、診断スクリーニングの分野で定評があるため、2022年の世界市場を独占しました。
  • 主要企業別継続的な製品改善努力も北米市場の成長に寄与している
  • アジア太平洋地域は、予測期間を通じて最も速い成長が見込まれています。これは、アジア諸国における主要プレイヤーの浸透と、主要プレイヤー別この分野への投資の増加に起因しています。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 市場の定義
    • 情報分析
    • 市場の形成とデータの視覚化
    • データの検証と公開
  • 調査の前提条件
  • 情報調達
    • 1次調査
  • 情報またはデータ分析
  • 市場の形成と検証
  • 市場モデル
  • 世界市場:CAGRの計算
  • 目的

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助的な市場見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 製品のビジネス分析

  • ロングリードシーケンス市場:製品の変動分析
  • 機器
  • 消耗品
  • サービス

第5章 技術のビジネス分析

  • ロングリードシーケンス市場:技術の変動分析
  • 単一分子のリアルタイムシーケンス
  • ナノポアシーケンシング
  • その他

第6章 ワークフローのビジネス分析

  • ロングリードシーケンス市場:ワークフローの変動分析
  • プリシーケンス
  • シーケンス
  • データ分析

第7章 用途のビジネス分析

  • ロングリードシーケンス市場:用途の変動分析
  • 全ゲノム配列決定
  • ターゲットシーケンシング
  • メタゲノミクス
  • RNAシーケンス
  • エピジェネティクス
  • その他

第8章 最終用途のビジネス分析

  • ロングリードシーケンス市場:最終用途の変動分析
  • 学術研究機関
  • 病院とクリニック
  • 製薬およびバイオテクノロジー企業
  • その他

第9章 地域ビジネス分析

  • 地域別:ロングリードシーケンス市場シェア、2022年および2030年
  • 北米
    • 北米のロングリードシーケンス市場、2018年~2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州のロングリードシーケンス市場、2018~2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋のロングリードシーケンス市場、2018年~2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカのロングリードシーケンス市場、2018~2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • MEAロングリードシーケンス市場、2018年~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第10章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies Limited
    • Quantapore, Inc.
    • Element Biosciences
    • BGI Genomics
    • Eurofins Genomics
    • Stratos Genomics, Inc.
    • MicrobesNG
    • NextOmics
    • New England Biolabs
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global long read sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global long read sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global long read sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global long read sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Global long read sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 9 North America long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 10 North America long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 11 North America long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 12 North America long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 13 North America long read sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 14 U.S. long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 17 U.S. long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 20 Canada long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 21 Canada long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Canada long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 23 Canada long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 25 Europe long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 26 Europe long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Europe long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 28 Europe long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 29 Europe long read sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Germany long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 31 Germany long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 32 Germany long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 33 Germany long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 34 Germany long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 35 UK long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 36 UK long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 37 UK long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 38 UK long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 39 UK long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 40 France long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 41 France long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 42 France long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 France long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 44 France long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 45 Italy long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 46 Italy long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 47 Italy long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 48 Italy long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 49 Italy long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 50 Spain long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 51 Spain long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 52 Spain long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 53 Spain long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 54 Spain long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 55 Denmark long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 56 Denmark long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 57 Denmark long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 58 Denmark long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 59 Denmark long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 60 Sweden long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 61 Sweden long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 62 Sweden long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 63 Sweden long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 64 Sweden long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 65 Norway long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 66 Norway long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 67 Norway long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Norway long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 69 Norway long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific long read sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 76 China long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 77 China long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 78 China long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 79 China long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 80 China long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 81 Japan long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 82 Japan long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 83 Japan long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Japan long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 85 Japan long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 86 India long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 87 India long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 88 India long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 89 India long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 90 India long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 91 Australia long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 92 Australia long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 93 Australia long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 94 Australia long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 95 Australia long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 96 Thailand long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 97 Thailand long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 98 Thailand long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 99 Thailand long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 100 Thailand long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 101 South Korea long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 102 South Korea long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 103 South Korea long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 104 South Korea long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 105 South Korea long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 106 Latin America long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 107 Latin America long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 108 Latin America long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 109 Latin America long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 110 Latin America long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America long read sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 112 Brazil long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 113 Brazil long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 115 Brazil long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 116 Brazil long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 117 Mexico long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 118 Mexico long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 119 Mexico long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 120 Mexico long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 121 Mexico long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 122 Argentina long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 123 Argentina long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 124 Argentina long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 125 Argentina long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 127 MEA long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 128 MEA long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 129 MEA long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 130 MEA long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 131 MEA long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 132 MEA long read sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 133 South Africa long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 134 South Africa long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 136 South Africa long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 143 UAE long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 144 UAE long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 145 UAE long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 146 UAE long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 147 UAE long read sequencing market by end-use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait long read sequencing market by product, 2018 - 2030 (USD Million)
  • Table 149 Kuwait long read sequencing market by technology, 2018 - 2030 (USD Million)
  • Table 150 Kuwait long read sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 151 Kuwait long read sequencing market by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait long read sequencing market by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Long read sequencing market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Long read sequencing market: Products outlook and key takeaways
  • Fig. 15 Long read sequencing market: Product movement analysis
  • Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Long read sequencing market: Technology outlook and key takeaways
  • Fig. 20 Long read sequencing market: Technology movement analysis
  • Fig. 21 Single molecule real time sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Nanopore sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Long read sequencing market: Workflow outlook and key takeaways
  • Fig. 25 Long read sequencing market: Workflow movement analysis
  • Fig. 26 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Long read sequencing market: Application outlook and key takeaways
  • Fig. 30 Long read sequencing Market: Application movement analysis
  • Fig. 31 Whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Targeted sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 RNA sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Epigenetics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Others applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Long read sequencing market: End-use outlook and key takeaways
  • Fig. 38 Long read sequencing market: End-use movement analysis
  • Fig. 39 Academic & research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Other end-uses market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Long read sequencing market: Regional outlook and key takeaways
  • Fig. 44 Long read sequencing market: Regional movement analysis
  • Fig. 45 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-3-68038-684-4

Long Read Sequencing Market Growth & Trends

The global long read sequencing market size is expected to reach USD 3.78 billion by 2030, registering a CAGR of 30.92% according to a new report by Grand View Research, Inc. Since the sequencing method has shown to be of utmost importance in modifying pharmaceuticals, there is also a cumulative market value for the expanding knowledge of long read sequencing. An increase in the adoption of these technologies for the analysis of structural variants is expected to drive the market throughout the forecast period.

Currently, a lot of research is being conducted which is forecast to give manufacturers a slight advantage as they develop new and advanced elongated read sequencing, as well as to open up a lot of other prospects in the long read sequencing market. Furthermore, owing to the ongoing COVID-19 pandemic, key players are working with public health laboratories and researchers around the world to support the current COVID-19 pandemic by rapid sequencing of the novel coronavirus SARS-CoV-2.

Companies are also involved in the development of workflows to characterize a wide range of pathogens in a sample. Recently, Oxford Nanopore Technologies developed LamPORE-a scalable, low-cost, rapid assay for the detection of SARS-CoV-2. A rise in the prevalence of genetic disorders combined with an increase in top manufacturers' R&D expenditures in long-read sequencing technology is projected to greatly advance the industry. The long read technique is mostly used to study genetic disorders for which disease loci are either well-known or strongly suspected.

In addition, the limitations of clinical disease research based on next-generation sequencing could be partially overcome by these technologies. Since longer reads from a single DNA molecule are used, long-read sequencing methods have a distinct advantage over other technology. Another driver of market expansion is the rising acceptance of contemporary methods for medical diagnosis. The portability and real-time speed of LRS technology are further factors contributing to its rising demand.

It is additionally utilized to create a precise reference map of the chromosome centromere. In addition, numerous biotech firms are creating cutting-edge technologies that combine a fresh approach to library preparation with tools for genomic analysis. Accordingly, a number of researches show that LRS technology is quite useful for identifying novel harmful mutations in human disorders with unidentified genetic origins. This offers a wealth of potential for researchers to use whole-genome sequencing (WGS) technology to develop medical genetics.

Long Read Sequencing Market Report Highlights

  • By technology, Single Molecule Real Time Sequencing (SMRT) dominated the market in 2021. This technique is gaining traction among professionals for various applications since the first commercial launch
  • Based on products, the consumables segment accounted for the largest share in 2022. Increasing demand for reagents & kits has majorly driven the segment growth
  • By application, the cancer segment captured the highest share in 2022. Increasing adoption of LRS in the field of cancer biology is anticipated to be the major factor for the segment growth
  • By workflow, sequencing is the dominating segment in 2022. Increasing research in the genomics arena has resulted in growing demand for sequencing services in the global market
  • Based on the end-users, academic research accounted for a significant share in 2022. The presence of a large number of biotechnology institutes that explore genomics methodologies is expected to propel the segment revenue generation
  • North America dominated the global market in 2022 owing to the presence of well-established proteomics, genomics, oncology & diagnostic screening fields in the region
  • Continuous efforts by key players to improve their product offerings is also contributing to the North America's regional market growth
  • Asia Pacific is anticipated to witness the fastest growth throughout the forecast period. This can be attributed to the growing penetration of key players in Asian countries as well as increasing investments in this field by key players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advantages Offered By Long Read Sequencing Techniques
      • 3.2.1.2. Increasing Applications In Clinical Sequencing And Analysis
      • 3.2.1.3. Advancements In Data Analysis Platforms
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Error Rates Of Long Read Technologies
      • 3.2.2.2. Technological Challenges Associated With Long Read Techniques
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Long Read Sequencing Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Consumables
    • 4.3.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Long Read Sequencing Market: Technology Movement Analysis
  • 5.2. Single Molecule Real Time Sequencing
    • 5.2.1. Single Molecule Real Time Sequencing Market, 2018 - 2030 (USD Million)
  • 5.3. Nanopore Sequencing
    • 5.3.1. Nanopore Sequencing Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Other Technologies Market, 2018 - 2030 (USD Million)

Chapter 6. Workflow Business Analysis

  • 6.1. Long Read Sequencing Market: Workflow Movement Analysis
  • 6.2. Pre-sequencing
    • 6.2.1. Pre-sequencing Market, 2018 - 2030 (USD Million)
  • 6.3. Sequencing
    • 6.3.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 6.4. Data Analysis
    • 6.4.1. Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Long Read Sequencing Market: Application Movement Analysis
  • 7.2. Whole Genome Sequencing
    • 7.2.1. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.3. Targeted Sequencing
    • 7.3.1. Targeted Sequencing Market, 2018 - 2030 (USD Million)
  • 7.4. Metagenomics
    • 7.4.1. Metagenomics Market, 2018 - 2030 (USD Million)
  • 7.5. RNA Sequencing
    • 7.5.1. RNA Sequencing Market, 2018 - 2030 (USD Million)
  • 7.6. Epigenetics
    • 7.6.1. Epigenetics Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 8. End-Use Business Analysis

  • 8.1. Long Read Sequencing Market: End-use Movement Analysis
  • 8.2. Academic & Research Institutes
    • 8.2.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.3. Hospitals & Clinics
    • 8.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Other End-uses Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Long Read Sequencing Market Share By Region, 2022 & 2030
  • 9.2. North America
    • 9.2.1. North America Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Competitive Scenario
      • 9.2.2.3. Regulatory Framework
      • 9.2.2.4. U.S. Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Competitive Scenario
      • 9.2.3.3. Regulatory Framework
      • 9.2.3.4. Canada Long Read Sequencing Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. UK Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Germany Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. France Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Competitive Scenario
      • 9.3.5.3. Regulatory Framework
      • 9.3.5.4. Italy Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Competitive Scenario
      • 9.3.6.3. Regulatory Framework
      • 9.3.6.4. Spain Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Competitive Scenario
      • 9.3.7.3. Regulatory Framework
      • 9.3.7.4. Denmark Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Competitive Scenario
      • 9.3.8.3. Regulatory Framework
      • 9.3.8.4. Sweden Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Competitive Scenario
      • 9.3.9.3. Regulatory Framework
      • 9.3.9.4. Norway Long Read Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Japan Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. China Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. India Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Australia Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Thailand Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. South Korea Long Read Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Brazil Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Mexico Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. Argentina Long Read Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. South Africa Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Saudi Arabia Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. UAE Long Read Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Kuwait Long Read Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Share Analysis, 2022
  • 10.4. Company Profiles/Listing
    • 10.4.1. Pacific Biosciences of California, Inc.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Oxford Nanopore Technologies Limited
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Quantapore, Inc.
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Element Biosciences
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. BGI Genomics
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Eurofins Genomics
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Stratos Genomics, Inc.
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. MicrobesNG
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. NextOmics
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. New England Biolabs
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives